Page 10 - Kenvue News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Kenvue. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Kenvue Today - Breaking & Trending Today
Kenvue (NYSE:KVUE – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 1.100-1.200 for the period, compared to the consensus EPS estimate of 1.260. The company issued revenue guidance of $15.6 billion-$15.9 billion, compared to the consensus revenue estimate of $15.9 billion. Kenvue […] ....
Kenvue (NYSE:KVUE – Get Free Report) updated its FY earnings guidance on Thursday. The company provided EPS guidance of $1.10-1.20 for the period. The company issued revenue guidance of ~$15.6-15.9 billion. Kenvue also updated its FY 2024 guidance to 1.100-1.200 EPS. Analysts Set New Price Targets A number of brokerages recently issued reports on KVUE. […] ....
W.G. Shaheen & Associates DBA Whitney & Co acquired a new stake in Kenvue Inc. (NYSE:KVUE – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 362,016 shares of the company’s stock, valued at approximately $7,269,000. Other institutional […] ....
Walt Disney posts better-than-expected earnings and boosts its dividend, PayPal issues disappointing guidance, and shares of Arm Holdings surge after a. ....
Kenvue forecast full-year profit below analysts' expectations after missing quarterly sales estimates on Thursday, as the Tylenol maker faces sluggish demand in China and slowing growth for skin and beauty products in the U.S. Consumers in China are being "more thoughtful" about their spending, CEO Thibaut Mongon told Reuters, adding the company planned to double down on efforts to expand its reach in the country. Kenvue is flagging a weakness when the world's second-largest economy battles a deepening property crisis, mounting deflationary risks and weak consumer and business confidence.The company, spun off from Johnson & Johnson in August, also missed Street estimates for fourth-quarter s. ....